AU7550994A - Sustained release oral compositions containing melatonin - Google Patents

Sustained release oral compositions containing melatonin

Info

Publication number
AU7550994A
AU7550994A AU75509/94A AU7550994A AU7550994A AU 7550994 A AU7550994 A AU 7550994A AU 75509/94 A AU75509/94 A AU 75509/94A AU 7550994 A AU7550994 A AU 7550994A AU 7550994 A AU7550994 A AU 7550994A
Authority
AU
Australia
Prior art keywords
sustained release
compositions containing
oral compositions
release oral
containing melatonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75509/94A
Inventor
James W. Ayres
Alfred J Lewy
Keith A Parrott
Robert L Sack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of AU7550994A publication Critical patent/AU7550994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU75509/94A 1993-07-26 1994-07-25 Sustained release oral compositions containing melatonin Abandoned AU7550994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9744393A 1993-07-26 1993-07-26
US097443 1993-07-26
PCT/US1994/008365 WO1995003043A1 (en) 1993-07-26 1994-07-25 Sustained release oral compositions containing melatonin

Publications (1)

Publication Number Publication Date
AU7550994A true AU7550994A (en) 1995-02-20

Family

ID=22263377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75509/94A Abandoned AU7550994A (en) 1993-07-26 1994-07-25 Sustained release oral compositions containing melatonin

Country Status (2)

Country Link
AU (1) AU7550994A (en)
WO (1) WO1995003043A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
DE4443175A1 (en) * 1994-12-05 1996-06-13 Jenapharm Gmbh New pulsatile drug form
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
IL144900A (en) 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments
EP1656939A1 (en) * 2004-11-10 2006-05-17 Pooger Properties Limited Use of melatonin in the manufacture of a medicament for treating cancer
GB2434099A (en) * 2006-01-12 2007-07-18 Roger Coghill Very low dosage melatonin compositions and their use in the treatment of the adverse effects of exposure to electromagnetic fields and radiation
CA2683436C (en) 2007-04-11 2016-07-26 John A. Mccarty Melatonin tablet and methods of preparation and use
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) * 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
NL2015272B1 (en) 2015-08-05 2017-05-02 Versailles B V Melatonin formulations and methods for preparation and use.
CN109922795B (en) * 2016-10-31 2021-10-08 纽里姆药物有限公司 Melatonin small tablet and preparation method thereof
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited Pharmaceutical composition of melatonin
JP6813922B1 (en) * 2019-12-10 2021-01-13 ノーベルファーマ株式会社 Melatonin-containing granules
WO2021144403A1 (en) * 2020-01-17 2021-07-22 Société des Produits Nestlé S.A. Dosage form with sustained release melatonin pellets
WO2021187608A1 (en) * 2020-03-18 2021-09-23 ノーベルファーマ株式会社 Novel granules and production method therefor
US20240316057A1 (en) 2021-01-15 2024-09-26 Galventa Ag Pulsatile release caffeine formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
ATE181670T1 (en) * 1991-05-09 1999-07-15 Neurim Pharma 1991 MEDICINAL PRODUCTS CONTAINING MELATONIN

Also Published As

Publication number Publication date
WO1995003043A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
AU5804194A (en) Oral compositions
AU7842794A (en) Oral compositions
AU6725496A (en) Peroxidase-activating oral compositions
AU4016095A (en) Oral compositions
AU4928396A (en) Oral compositions
AU3650895A (en) Oral compositions
AU1118092A (en) Sustained release compositions
AU3736295A (en) Denture stabilizing compositions
AU5939394A (en) Sustained release compositions
AU5151293A (en) Oral hygiene composition
AU2372095A (en) Oral compositions
AU6983594A (en) Composition for oral cavity
AU6776494A (en) Oral compositions
AU7727196A (en) Oxygen generating compositions
AU7550994A (en) Sustained release oral compositions containing melatonin
GB9400134D0 (en) Oral composition
GB9513694D0 (en) Oral compositions
GB9515597D0 (en) Oral compositions
AU6464098A (en) Dental composition
AU2739097A (en) Enhanced zinc containing oral composition
AU7345094A (en) Oral compositions
AU2427895A (en) Oral compositions
AU7453496A (en) Enhanced stannous oral composition
AU1096597A (en) Oral compositions containing peroxide with stable colorant
AU4756996A (en) Oral compositions